SEZI — Senzime AB (publ) Share News
0.000.00%
- SEK551.04m
- SEK543.27m
- SEK104.02m
Brief: Senzime Signs Contract With U.S. University Hospital System
Brief: Senzime Carries Out Directed Share Issue Of SEK 117 Mln
Brief: Senzime Says Directed Share Issue Fully Subscribed
Brief: Senzime Secures Major Us Hospital Contract
Brief: Senzime Submits Application For Cross-Trading At OTCQX In The US
Brief: Senzime Carries Out Directed Share Issue Of Approx SEK 56 Mln
Brief: Senzime Q2 EBITDA at SEK -30.201 Million
Brief: Senzime Gets Large Order From Leading California University Hospital System
Brief: Senzime Confirms Clinical Advantage Of Tetragraph System In US Study
Brief: Senzime Expands Production Capacity On Increasing Market Demand
Brief: Senzime Gets Granted European Patent For Tetrasens
Brief: Senzime Outlicenses Exspiron In Chinese Market
Brief: Senzime YTD May 2023 Sales Have Tripled Compared To Same Period Last Year
Brief: Senzime Expands Partnership With Japanese Licensee
Brief: Senzime Sees Continued High Demand On Main Markets For 2023
Brief: Senzime Q1 EBITDA at SEK -26.5 Million
Brief: Senzime Raises SEK 91.9 Million Through Rights Issue
Brief: Senzime Gets Approval For Its Pediatric Sensor In Japan
Brief: Senzime Q4 EBITDA Loss Widens To SEK 37.5 Mln